Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Other Accumulated Expenses (2022 - 2025)

ASP Isotopes has reported Other Accumulated Expenses over the past 3 years, most recently at $1.3 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 6.52% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 6.52% increase, with the full-year FY2025 number at $1.3 million, up 6.52% from a year prior.
  • Other Accumulated Expenses reached $1.3 million in Q4 2025 per ASPI's latest filing, down from $3.7 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $3.7 million in Q3 2025, with the low at $18606.0 in Q4 2023.
  • The 3-year median for Other Accumulated Expenses is $1.2 million (2024), against an average of $1.2 million.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 6655.89% in 2024, then plummeted 93.45% in 2025.
  • Tracing ASPI's Other Accumulated Expenses over 3 years: stood at $18606.0 in 2023, then skyrocketed by 6655.89% to $1.3 million in 2024, then grew by 6.52% to $1.3 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $1.3 million, $3.7 million, and $489584.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.